Loma Linda, California 92354


The study will measure the effects of eye exams on markers of stress in the urine. In addition, measurements will be taken to show the effects of stress on brain activity, O2 sats, and blood flow.


Inclusion Criteria: - Premature infants between 24 -32 weeks of gestational age Exclusion Criteria: - Infants scheduled for laser eye surgery on the day of the examination - Infants with intraventricular hemorrhage ≥ grade 3 (Papile classification) diagnosed by head ultrasound - Infants receiving the following medications: morphine, fentanyl, methadone, midazolam, lorazepam, muscle relaxants, phenobarbital, phenytoin, levetiracetam - Renal injury defined with plasma creatinine > 1.5 mg/dL - Severe cyanotic congenital heart disease - Unstable respiratory distress (hypoxemia PaO2 < 50 mm Hg or SpO2 < 90%)



Primary Contact:

Principal Investigator
Andrew Hopper, MD
Loma Linda University

Andrew Hopper, MD
Phone: (909) 558-7448

Backup Contact:

Danilyn Angeles, PhD
Phone: 909-558-7563

Location Contact:

Loma Linda, California 92354
United States

Danilyn M Angeles, PhD
Phone: 909-558-7563
Email: dangeles@llu.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.